Cytegen Corporation
Organization
People
Tomas Alberto Prolla
R Blake Hill
Sources: reporter.nih.gov
Grants and prizes
R41, Determination of circulation factors that mediate the health benefits of exercise in mitochondrial aging, R41AG065131, $252K, 2020–2022, Aug 30, 2020
R41, Selection and Development of a Lead Biologic for Treating Mitochondrial Disorders, R41AG059530, $242K, 2018–2020, Jun 13, 2018
Sources: reporter.nih.gov
Named in competing interests
Consulting or advice, Board or leadership role, Oct 5, 2022
Sources: pubmed.ncbi.nlm.nih.gov